
PROVEXIS PLC — Investor Relations & Filings
Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-20 | English | |
| Half-year Financial Report | 2025-12-31 | English | |
| Result of AGM | 2025-11-21 | English | |
| Group of companies' accounts made up to 2025-03-31 | 2025-11-12 | English | |
| Final Results | 2025-10-30 | English | |
| Delay in publication of annual accounts | 2025-09-30 | English |
Browse filings by year
23 years- 2026 1 filing
- 2025 6 filings
- 2024 8 filings
- 2023 7 filings
- 2022 8 filings
- 2021 22 filings
- 2020 10 filings
- 2019 12 filings
- 2018 13 filings
- 2017 29 filings
- 2016 23 filings
- 2015 12 filings
- 2014 16 filings
- 2013 31 filings
- 2012 1 filing
- 2011 1 filing
- 2010 1 filing
- 2009 1 filing
- 2008 1 filing
- 2007 1 filing
- 2006 1 filing
- 2005 1 filing
- 2004 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 46579349 | Holding(s) in Company | 2026-05-20 | English | ||
|
2025
6 filings
| |||||
| 11554037 | Half-year Financial Report | 2025-12-31 | English | ||
| 8501780 | Result of AGM | 2025-11-21 | English | ||
| 46820326 | Group of companies' accounts made up to 2025-03-31 | 2025-11-12 | English | ||
| 8062473 | Final Results | 2025-10-30 | English | ||
| 7939561 | Delay in publication of annual accounts | 2025-09-30 | English | ||
| 5562618 | Grant of Options and Warrants | 2025-01-07 | English | ||
|
2024
8 filings
| |||||
| 5560235 | Total Voting Rights | 2024-12-31 | English | ||
| 5560463 | Half-year Report | 2024-12-31 | English | ||
| 5556890 | Purchase of Fruitflow® II SD & royalty payment | 2024-12-18 | English | ||
| 5532742 | Result of AGM | 2024-10-25 | English | ||
| 46820328 | Group of companies' accounts made up to 2024-03-31 | 2024-10-11 | English | ||
| 5521115 | Final Results | 2024-09-30 | English | ||
| 5447930 | Total Voting Rights | 2024-04-30 | English | ||
| 5434160 | Issue of Equity - purchase of Fruitflow® II SD | 2024-03-28 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for PROVEXIS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
HEALIOS K.K.
Clinical-stage biotech developing regenerative medicine and…
|
4593 | JP | Professional, scientific and te… |
|
HeartSciences Inc.
Medical technology company applying AI to electrocardiograp…
|
HSCS | US | Professional, scientific and te… |
|
Heartseed Inc.
Clinical-stage biotech developing regenerative medicine for…
|
219A | JP | Professional, scientific and te… |
|
Hemostemix Inc.
Clinical-stage biotech developing autologous stem cell ther…
|
HEM | CA | Professional, scientific and te… |
|
Herantis Pharma Oyj
A clinical-stage biotech developing therapies for neurodege…
|
HRTIS | FI | Professional, scientific and te… |
|
HEXIMA LIMITED.
Develops plant-derived proteins for human therapeutics and …
|
HXL | AU | Professional, scientific and te… |
|
Hipower Energy Spolka Akcyjna
Develops and commercializes hydrogen-based solutions and fu…
|
HPE | PL | Professional, scientific and te… |
|
HitGen Inc.
Discovers small molecule drug candidates using a DNA-encode…
|
688222 | CN | Professional, scientific and te… |
|
HLB bioStep Co.,Ltd.
A non-clinical CRO providing drug development services, spe…
|
278650 | KR | Professional, scientific and te… |
|
HLB PANAGENE Co., LTD.
Specializes in PNA-based molecular diagnostics for oncology…
|
046210 | KR | Professional, scientific and te… |
PROVEXIS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7862/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7862 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7862 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7862 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7862}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PROVEXIS PLC (id: 7862)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.